JP

Jay Pragda

Active Director Director DIN 07867602
DIN 07867602 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Jay Pragda

Data last updated:

Jay Pragda is a Director at Agonist Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Agonist Pharmaceuticals Private Limited reported revenue of ₹13.99 Cr (FY 2022).

DIN 07867602
Primary Designation Director
Industry Pharma
First Appointment 06 Jul 2017
Oldest Company Age 9 yrs
Largest company Agonist Pharmaceuticals Private Limited · ₹13.99 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jul 20172017₹13.99 Cr (FY 2022)Active

Directorship timeline

Open interactive timeline →
Agonist Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jay Pragda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Pragda

Jay Pragda currently holds 1 directorship: Agonist Pharmaceuticals Private Limited (Director, since 06 Jul 2017, revenue ₹13.99 Cr (FY 2022)).

Jay Pragda was first appointed on 06 Jul 2017 as Director at Agonist Pharmaceuticals Private Limited.

The current boards of Jay Pragda's companies include Bharatbhai Ramjibhai Kamani (Agonist Pharmaceuticals Private Limited), Dhaval Bharatbhai Kamani (Agonist Pharmaceuticals Private Limited), Rohit Vallabhbhai Madariya (Agonist Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available